Patent · US Active

Kallikrein-inhibitor therapies

US9114144B2 · kind B2 · utility

7Cited by
159References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2011
Grant dateAug 25, 2015
Priority date—
Expiry dateJan 1, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods are described for preventing or reducing ischemia, e.g., cerebral ischemia, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia, in a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.